Global Medical cannabis leader expands dispensary footprint to Gainesville, one of Florida’s most densely populated metropolitan areas and provides update on new cultivation and manufacturing facility Gainesville dispensary to provide differentiated product offering with portfolio of proprietary,

Global medical cannabis leader launches west coast expansion plan in California’s largest, limited license metropolitan market Nationally proven high-touch, provider-based dispensary model and proprietary pharmaceutical-quality products bring novel, impactful and personalized cannabis-based health

First-of-their-kind results to enhance patient experience and efficacy of Columbia Care products by further informing and personalizing treatment recommendations to support optimal product dosing and formulation selection NEW YORK--(BUSINESS WIRE)-- Columbia Care Inc.

Currently available in multiple markets, the CNC card will enable cannabis consumers and dispensaries nationwide to transact electronically using credit in all of Columbia Care’s markets by the end of 2019 First legal, transparent and highly scalable credit card solution available to fast-growing

IRB-approved collaboration initiated to demonstrate clinical value of Columbia Care’s precisely formulated, pharmaceutical-quality cannabis-based medicine,   ClaraCeed™,   through rigorous scientific research with leading medical practice in significant, underserved patient population NEW YORK &

First quarter 2019 revenue increase of 45% over prior year Completion of go-public transaction provides capital to fund long-term growth prospects Expansion of US footprint with 13 lease signings in Florida, dispensary openings in Brooklyn, NY and San Diego, CA, reinforcing organic growth strategy

Columbia Care to partner with experts at Montefiore Medical Center and Albert Einstein College of Medicine for initial phase of nationwide study on medical cannabis’s impact on opioid use for pain NEW YORK--(BUSINESS WIRE)-- Columbia Care Inc. (“Columbia Care”, or the “Company”) (NEO: CCHW), a

Organic growth continues to drive revenue increases of 45% for Q1 2019 and 35% for FY 2018 on year-over-year basis Closing of go-public transaction to accelerate strategy execution and long-term growth prospects NEW YORK--(BUSINESS WIRE)-- Columbia Care Inc. (“Columbia Care”, or the “Company”)

Findings demonstrate key differences in demographics and choice of medical cannabis product between patients with cancer and without cancer NEW YORK, March 26, 2019 (GLOBE NEWSWIRE) -- Columbia Care LLC, one of the nation’s leading medical cannabis companies, today announced the peer-reviewed

One of six companies awarded fully integrated license out of 146 applicants New Jersey will be the 14 th state where Columbia Care is licensed to operate NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Columbia Care LLC (“Columbia Care”), one of the nation’s leading medical cannabis companies, today